This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Management

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Patients with noninvasive fungal otitis externa should be treated with intense debridement and cleansing, and topical antifungals (1)

  • topical antifungals, such as clotrimazole and miconazole, are potentially safe choices for the treatment of otomycosis, especially in patients with a perforated eardrum.

UK guidance suggests (2) that if fungal infection is suspected (signs of fungal growth in ear canal): Prescribe a topical antifungal preparation

  • .for mild-to-moderate and uncomplicated fungal infections, consider one of the following options:
    • topical antifungal: clotrimazole 1% solution
    • acetic acid 2% spray (unlicensed use)
    • topical preparation containing clioquinol and a corticosteroid for example Locorten-Vioform®
  • seek specialist advice if there is inadequate response.

The oral triazole drugs e.g. itraconazole, are effective against Candida and Aspergillus, with good penetration of bone and the central nervous system. These drugs are essential in the treatment of patients with malignant fungal otitis externa complicated by mastoiditis and meningitis (1).

Reference:

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.